Skip to Main Content

neurology

Here’s the latest research and news on neurology, the medical specialty that deals with the nervous system. Topics include Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, stroke and traumatic brain injury.

Latest

Biotech Damian Garde

STAT Plus: A ‘renaissance in neuroscience’ could deliver a fresh crop of psychiatric medicines

Adam's Take Adam Feuerstein

STAT Plus: Annovis Bio delivers candor on its Parkinson’s study, even if it doesn’t inspire much confidence

Health tech Mario Aguilar

STAT Plus: Cognito raises $35 million for Alzheimer’s treatment device, touts benefits compared to drugs

Health tech Mario Aguilar

STAT Plus: Rune Labs, which makes an app to track Parkinson’s symptoms, raises $12 million

Health Elaine Chen

STAT Plus: Wegovy may have another helpful trick: fighting inflammation via the brain, study finds

Health Usha Lee McFarling

Life-extending epilepsy surgery performed less often in Black children, study finds

In the Lab Matthew Herper

In experiment, electrical stimulation of the spinal cord helps a patient with Parkinson’s to walk

Special Report Mario Aguilar

STAT Plus: For Parkinson’s disease, advances spurred by Apple Watch offer a glimmer of hope

All Coverage

Health tech Lizzy Lawrence

STAT Plus: For brain-computer interfaces, the commercial hurdles may be bigger than scientific ones

Pharmalot Ed Silverman and Rachel Cohrs

Policy experts call on Medicare to ensure data from Alzheimer’s drug registries is shared publicly

advertisement

Politics Annalisa Merelli

STAT Plus: Mitch McConnell’s abrupt episode has an important public health takeaway

Health Simar Bajaj

Why nearly half of Americans with Parkinson’s don’t see a neurologist

Pharmalot Ed Silverman

STAT Plus: Bitter infighting leads 15 chapters to break away from leading ALS advocacy group

Pharmalot Ed Silverman

STAT Plus: FDA removes neurologist with financial ties to Eisai and Biogen from Alzheimer’s advisory panel

Health tech Lizzy Lawrence

STAT Plus: Neuralink can now study its brain implant in humans, but it’s still catching up to its peers

Biotech Damian Garde

STAT Plus: Sam Waksal and Jeremy Levin plot ‘the turnaround story of the century’

Health Matthew Herper

A Parkinson’s ‘game changer,’ backed by Michael J. Fox, could lead to new diagnostics and, someday, treatments

First Opinion Michael J. Fox

Michael J. Fox: As a Parkinson’s patient, I felt a little left behind by biology’s century — until now

Biotech Adam Feuerstein

STAT Plus: Under protest, FDA to convene advisory panel to review controversial cell therapy for ALS

Adam's Take Adam Feuerstein

STAT Plus: Amylyx’s ALS drug launch starts strong. That could be trouble for the FDA

Pharmalot Ed Silverman

STAT Plus: Veterans Health Administration will cover the newest Alzheimer’s drug

Pharmalot Ed Silverman and Andrew Joseph

STAT Plus: Leading ALS advocacy group roiled by infighting over money and priorities

Health Lauren Gravitz

Scientists are finding increasing evidence for a link between air pollution and neurodegenerative diseases like Alzheimer’s

The Pharmalot View Ed Silverman

STAT Plus: Why a tone-deaf Regeneron executive deserved to be booed over Alzheimer’s drug remarks

Biotech Matthew Herper and Allison DeAngelis

STAT Plus: ‘This is not a cure’: Consensus begins to emerge on new Alzheimer’s drug